Results 11 to 20 of about 11,891 (157)

A case of maturity-onset diabetes of the young type 4 in Korea [PDF]

Annals of Pediatric Endocrinology & Metabolism, 2022
Maturity-onset diabetes of the young (MODY) is a rare, autosomal dominant disease characterized by non-ketogenic diabetes mellitus (DM). MODY type 4, caused by PDX1 mutation, is a very rare subtype of MODY, especially in Korea.
Geu-Meum Park, Soojung Lee, Ja Young Seo, Kyung In Lim   +3 more
doaj   +1 more source

Targeted gene panel analysis of Japanese patients with maturity‐onset diabetes of the young‐like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes

Journal of Diabetes Investigation, 2023
Aims/Introduction To investigate the genetic background of Japanese patients with suspected maturity‐onset diabetes of the young (MODY). Materials and Methods On 340 proband patients referred from across Japan, genomic variants were analyzed using a ...
Tohru Yorifuji, Yoh Watanabe, Kana Kitayama, Yuki Yamada, Shinji Higuchi, Jun Mori, Masaru Kato, Toru Takahashi, Tokuko Okuda, Takane Aoyama   +9 more
doaj   +1 more source

When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?

Archives of Endocrinology and Metabolism, 2022
Objetivo: Maturity onset diabetes of the young (MODY) patients have clinical heterogeneity as shown by many studies. Thus, often it is misdiagnosed to type 1 or type 2 diabetes(T2DM).
Özlem Üstay, Tugçe Apaydın, Onur Elbasan, Hamza Polat, Gizem Günhan, Ceyda Dinçer, Lamia Şeker, Esra Arslan Ateş, Ayşegül Yabacı, Ahmet lter Güney, Dilek Gogas Yavuz   +10 more
doaj   +1 more source

Testing for monogenic diabetes is lower than required to reveal its true prevalence in an Australian population

Diabetes Epidemiology and Management, 2022
Aims: Monogenic diabetes is responsible for 1–5% of all cases of diabetes. A previous Australian study estimated a prevalence of 89 cases per million adults, or one in 280 people with diabetes.
Aleena S. Ali, Jay C.S. Wong, Ainsley Campbell, Elif I. Ekinci   +3 more
doaj   +1 more source

Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)

Journal of Diabetes Investigation, 2022
Maturity‐onset of diabetes of the young (MODY) are monogenic forms of diabetes characterized by early onset diabetes with autosomal dominant inheritance.
Mustafa Tosur, Louis H Philipson
doaj   +1 more source

Hyperglycemia in pediatric age: could it be maturity onset diabetes of the young? Case reports and review of the literature [PDF]

Annals of Pediatric Endocrinology & Metabolism, 2019
Maturity Onset Diabetes of the Young (MODY) includes a clinically and genetically heterogeneous group of diabetes subtypes with MODY-2 being the second most prevalent form.
Mafalda Cascais, Ester Pereira, Alexandra Vieira, Margarida Venâncio, Lina Ramos, Pascoal Moleiro   +5 more
doaj   +1 more source

Association of GCK Gene Promoter Polymorphism and their Role in its mRNA Expression among Type 2 Diabetes Mellitus Patients [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Glucokinase (GCK) gene alteration or inactivation leads to Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes. Alterations in GCK gene has been shown to be associated with increased risk of type 2 diabetes, hyperglycaemia
WASEEM FATIMA, Farah Khan, Ashraf Ali, Amit Kumar Verma   +3 more
doaj   +1 more source

Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment [PDF]

Yeungnam University Journal of Medicine, 2020
Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic disorders characterized by ß-cell dysfunction. MODY accounts for between 2% and 5% of all diabetes cases, and distinguishing it from type 1 or type 2 diabetes is
Kyung Mi Jang
doaj   +1 more source

Identification of Maturity-Onset Diabetes of the Young Caused by Glucokinase Mutations Detected Using Whole-Exome Sequencing [PDF]

Endocrinology and Metabolism, 2017
Glucokinase maturity-onset diabetes of the young (GCK-MODY) represents a distinct subgroup of MODY that does not require hyperglycemia-lowering treatment and has very few diabetes-related complications. Three patients from two families who presented with
Eun-Hee Cho, Jae Woong Min, Sun Shim Choi, Hoon Sung Choi, Sang-Wook Kim   +4 more
doaj   +1 more source

Pregnancy outcome of Japanese patients with glucokinase–maturity‐onset diabetes of the young

Journal of Diabetes Investigation, 2019
Aims/Introduction Glucokinase–maturity‐onset diabetes of the young (GCK‐MODY; also known as MODY2) is a benign hyperglycemic condition, which generally does not require medical interventions.
Yuki Hosokawa, Shinji Higuchi, Rie Kawakita, Ikue Hata, Tatsuhiko Urakami, Tsuyoshi Isojima, Kei Takasawa, Yohei Matsubara, Haruo Mizuno, Yoshihiro Maruo, Katsuyuki Matsui, Katsuya Aizu, Kazuhiko Jinno, Shunsuke Araki, Yasuko Fujisawa, Koji Osugi, Chikako Tono, Yasuhiro Takeshima, Tohru Yorifuji   +18 more
doaj   +1 more source